Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway

通过 OBSL1-CUL7-CUL9-p53 途径控制微管和基因组完整性

基本信息

  • 批准号:
    9421591
  • 负责人:
  • 金额:
    $ 7.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-07-17 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During mitosis, chromosomes are accurately segregated to daughter cells by a microtubule-based structure called the mitotic spindle. It has long been recognized that undetected microtubule damage causes mitotic defects and genetic instability which renders cells susceptible to tumorigenesis. A well-established pathway, the spindle assembly checkpoint pathway, ensures equal separation of sister chromatids and is conserved in all eukaryotes. We recently uncovered evidence for a new pathway, unique to vertebrates, which can also sense microtubule stress. Combined genetic, cellular and biochemical analyses have led to the finding that CUL7 and CUL9, two cytoplasmically localized E3 ubiquitin ligases which can bind to p53, control mitosis and cytokinesis by sensing microtubule stress. Deletion of Cul9 in mice resulted in wide spread polyploidy, spontaneous tumor development, and rendered mice susceptible to carcinogenesis indicating that Cul9 is a tumor suppressor. Conversely, gain of function in CUL9 promoted a p53-dependent apoptosis. We further found that depletion of CUL7 or its binding partner OBSL1 caused severe microtubule damage, abnormal chromatid alignment, and defects in cytokinesis and widespread mitotic cell death, all of which can be rescued by simultaneous depletion of CUL9. These extensive preliminary results led us to propose that there exists in vertebrates an OBSL1-CUL7-CUL9-p53 pathway that senses microtubule stress during mitosis and is functionally separate from the well-established spindle-assembly checkpoint. We propose here a series of rigorous genetic and biochemical experiments to examine the role of this novel OBSL1-CUL7-CUL9-p53 pathway in maintaining genome integrity. In the first Aim, we will generate Cul7-Cul9 and Obsl1-Cul9 double knockout mice to genetically test the functional relationship of CUL7 and CUL9 and between OBSL1 and CUL9 in vivo. In the second Aim, we will genetically test the contribution of p53 to pathway by generating two separate knock-in mice, each with a point mutation in the p53 binding domain of CUL7 and CUL9. Finally, we will biochemically test how ubiquitylation contributes to the mechanism of the OBSL1-CUL7-CUL9-p53 pathway.
描述(由申请人提供):在有丝分裂过程中,染色体通过称为有丝分裂纺锤体的基于微管的结构将染色体准确地隔离到子细胞上。长期以来,人们已经认识到,未检测到的微管损伤会导致有丝分裂缺陷和遗传不稳定性,从而使细胞容易受到肿瘤发生的影响。一条公认的途径,即主轴组件检查点途径,可确保姐妹染色单体相等的分离,并在所有真核生物中保守。最近,我们发现了脊椎动物独有的新途径的证据,该途径也可以感觉到微管应激。结合的遗传,细胞和生化分析导致发现CUL7和CUL9,两个细胞质局部局部的E3泛素连接酶可以通过感测微管应激与p53结合,对照有丝分裂和细胞因子。小鼠中CUL9的缺失导致广泛的多倍体,自发的肿瘤发育,并使小鼠易受致癌作用,表明CUL9是肿瘤抑制器。相反,CUL9的功能增益促进了p53依赖性凋亡。我们进一步发现,CUL7或其结合伴侣obsl1的耗竭会导致严重的微管损伤,异常的染色体比对,以及细胞因子和广泛的有丝分裂细胞死亡的缺陷,所有这些死亡都可以通过同时耗尽CUL9来挽救。这些广泛的初步结果使我们提出脊椎动物中存在一种obsl1-Cul9-Cul9-p53途径,该途径在有丝分裂过程中感受到微管应激,并且在功能上与已建立的纺锤体组装检查点具有分离。我们在这里提出了一系列严格的遗传和生化实验,以检查这种新型的Castl1-Cul7-Cul9-P53途径在维持基因组完整性中的作用。在第一个目标中,我们将生成Cul7-Cul9和obsl1-Cul9双基因敲除小鼠,以遗传测试CUL7和CUL9的功能关系以及Vivo中的obsl1和Cul9之间。在第二个目标中,我们将通过产生两只独立的敲入小鼠来从基因测试p53对途径的贡献,每只小鼠在CUL7和CUL9的p53结合结构域中都有一个点突变。最后,我们将在生化上测试泛素化如何有助于obsl1-cul7-cul9-p53途径的机理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUE XIONG其他文献

YUE XIONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUE XIONG', 18)}}的其他基金

Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8611905
  • 财政年份:
    2012
  • 资助金额:
    $ 7.03万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8434844
  • 财政年份:
    2012
  • 资助金额:
    $ 7.03万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    9010942
  • 财政年份:
    2012
  • 资助金额:
    $ 7.03万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8219796
  • 财政年份:
    2012
  • 资助金额:
    $ 7.03万
  • 项目类别:
Cancer Cell Biology
癌细胞生物学
  • 批准号:
    8340183
  • 财政年份:
    2011
  • 资助金额:
    $ 7.03万
  • 项目类别:
Program Leaders
项目负责人
  • 批准号:
    8340160
  • 财政年份:
    2011
  • 资助金额:
    $ 7.03万
  • 项目类别:
The Cullin-ROC Family of E3 Ubiquitin Ligases
E3 泛素连接酶的 Cullin-ROC 家族
  • 批准号:
    8085407
  • 财政年份:
    2010
  • 资助金额:
    $ 7.03万
  • 项目类别:
The Physiological Function and Regulation of INK4 Genes
INK4基因的生理功能及调控
  • 批准号:
    7913867
  • 财政年份:
    2009
  • 资助金额:
    $ 7.03万
  • 项目类别:
The ROC-Cullin Family of E3 Ubiquitin Ligases
E3 泛素连接酶的 ROC-Cullin 家族
  • 批准号:
    6561926
  • 财政年份:
    2003
  • 资助金额:
    $ 7.03万
  • 项目类别:
Function and Mechanism of CUL4 E3 Ligases in Human Diseases
CUL4 E3 连接酶在人类疾病中的功能和机制
  • 批准号:
    8642184
  • 财政年份:
    2003
  • 资助金额:
    $ 7.03万
  • 项目类别:

相似海外基金

An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors
用于靶向治疗非典型畸胎瘤/横纹肌样瘤的 IGF-1R 靶向肽药物缀合物
  • 批准号:
    10760549
  • 财政年份:
    2023
  • 资助金额:
    $ 7.03万
  • 项目类别:
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
Vpr 介导的细胞周期失调在 HIV 相关肾病中的作用
  • 批准号:
    10678878
  • 财政年份:
    2022
  • 资助金额:
    $ 7.03万
  • 项目类别:
Parameters that determine cell fate during mitotic arrest
有丝分裂停滞期间决定细胞命运的参数
  • 批准号:
    10617385
  • 财政年份:
    2022
  • 资助金额:
    $ 7.03万
  • 项目类别:
Parameters that determine cell fate during mitotic arrest
有丝分裂停滞期间决定细胞命运的参数
  • 批准号:
    10409136
  • 财政年份:
    2022
  • 资助金额:
    $ 7.03万
  • 项目类别:
Identification of a targeted anti-mitotic agent that degrades Myc and specifically induces cancer cell death
鉴定可降解 Myc 并特异性诱导癌细胞死亡的靶向抗有丝分裂剂
  • 批准号:
    10534020
  • 财政年份:
    2022
  • 资助金额:
    $ 7.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了